If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Reference standard · Research use only
Modified HGH fragment 176–191 (anti-obesity drug candidate)
Price, MOQ and lead time come in your written quote — usually within 24 hours. No account needed.
Compound facts
| Name | AOD9604 |
|---|---|
| CAS number | 221231-10-3 |
| PubChem CID | 71300630 |
| Molecular formula | C78H123N23O23S2 |
| Molecular weight | 1815.1 g/mol |
| Sequence | YLRIVQCRSVEGSCGF (16 residues; Cys7-Cys14 intramolecular disulfide) |
| Appearance | White to off-white lyophilized powder |
| Purity specification (HPLC) | ≥ 99.0% |
| On every batch COA | RP-HPLC purity · ESI-MS identity · Bacterial endotoxin · Fill amount (content per vial) |
| On request | LC-MS/MS sequence confirmation · Net peptide content · Water content (Karl Fischer) · Counter-ion content (e.g. acetate, TFA) · Microbial limits |
| Storage | 2–8°C, protect from light |
| Strengths per vial | 2 mg · 5 mg · 6 mg · 10 mg |
| Pack | 10 vials per kit |
| MOQ | On request |
| Lead time | 10–18 days |
| Use | Research use only — not for human or veterinary use |
Identity data from the Lyochem product catalogue, checked against PubChem and registry records. The batch COA of your lot is the record for that lot's results. How to verify a COA
Lot documentation
Values belong to the lot. Ask for the COA of the offered lot before you order.
Independent test fails? Full refund. How it works
Research documentation
AOD9604 is supplied for laboratory research. Contact sales to confirm the available identity, purity, and lot records, and discuss the evidence your assay or method-development project requires.
Overview
AOD9604 is a lipolytic peptide analog built from the C-terminal 176-191 region of human growth hormone, the segment thought to trigger fat-cell lipolysis through a mechanism independent of the GH receptor. It carries an extra N-terminal tyrosine — added to enable iodination for preclinical tracking — while the full-length HGH molecule's central anabolic regions are absent, so the fat-mobilizing activity is retained without the broader anabolic profile. Originating at Monash University in Australia, it reached Phase 2 obesity trials, did not gain regulatory approval, and subsequently moved into research-use and, in some jurisdictions, dietary-supplement channels. Lyochem supplies lyophilized AOD9604 to a ≥99.0% HPLC purity specification with a batch-specific COA available from sales. Every released lot comes with its batch COA covering RP-HPLC purity and ESI-MS confirmation of the tyrosine-modified mass; residual water is available on request and listed on the COA when tested. That N-terminal tyrosine is exactly what separates AOD9604 from the plain HGH Fragment 176-191; the two are distinct molecules, and the reference standard listed here is AOD9604. Fills of 2, 5, and 10 mg span the usual research workflows.
Applications & buyer fit
GH-axis peptides ship to research labs studying somatotropic-pathway pharmacology and related models. Ask sales for the matching batch COA. Sequence, counter-ion, or stability evidence beyond that record is included only when required by a written project scope and agreed before quotation.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Every lot has its own batch-specific CoA — RP-HPLC purity, ESI-MS identity, bacterial endotoxin and fill amount, plus any analytical scope agreed at quote stage — tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Other formats

AOD9604 is also kept as a solution in nasal spray bottles.
| Contents | 2 mg, 5 mg, 10 mg |
|---|---|
| Fill volume | 10 mL or 20 mL |
| Minimum | 10 bottles per content and volume |
| Stock | Held in the United States, shipped within the US |
Regulatory note
Sold for Research Use Only under the receiving laboratory's institutional and jurisdictional regulations. Not a finished dosage form, not labelled for human administration — Lyochem's GH-axis lots are scoped to research workflows only. Buyers studying somatotropic pharmacology should specify the counter-ion form (acetate by default) and any pulse-vs-sustained study design notes at quote stage.
Selected literature
Frequently asked questions
AOD9604 corresponds to the C-terminal region of GH, so identity work centers on confirming that specific fragment rather than any larger GH species. RP-HPLC establishes chemical purity and a characteristic retention profile, ESI-MS confirms the expected fragment mass and separates it from longer or truncated GH-derived sequences, and LC-MS/MS sequence verification, available on request, reads the residue ladder to confirm the intended C-terminal sequence. This matters because a mass in the right neighborhood is not proof of the correct fragment; full sequence coverage is what confirms the supplied material is the intended peptide and not a related GH-region species.
Like most synthetic peptides supplied as a salt, the vial mass is not all peptide, so the COA should distinguish gross fill weight from net peptide content after accounting for the counter-ion, typically acetate, and for bound water measured by Karl Fischer. Reporting the salt form and residual trifluoroacetate where relevant lets researchers dose by actual peptide mass instead of vial weight, which is essential when comparing lipolytic readouts across lots. Amino-acid analysis can anchor the net-content figure, and retaining a qualified reference aliquot supports lot-to-lot consistency checks over time.
Yes: 2 mg, 5 mg, 10 mg, in 10 mL or 20 mL bottles, minimum 10 bottles per content and volume. This format is held in the United States and shipped within the US; contact sales for availability and a quotation.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides